Nanorab-LSR Cap.

Product Description

Nanorab-DSR Cap.

(Rabeprazole 20mg. & Domperidone 20mg. Sustained Release & 10mg. Immediate Release)

Indications -

• Levosulpride - the new prokinetic agent, demonstrates greater central antidopaminergic, antiemetic and antidyspeptic effects

• Reliable Combination with Rabeprazole which starts working immediately and keeps controlling acid reflux 24 hours.

•  Well tolerated by patients as compared to domperidone with high safety profile.